circRNA basic information
circBase ID: -
Name: hsa_circ_HIPK3
Synonym: circHIPK3
Host Gene: HIPK3
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0021042
MONDO name: glioma
Disease details: glioma
Disease DO ID:
-
Disease MeSH ID:
D005910
Disease NCIt ID:
C3059
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

glioma tissues

Cell lines:

A172; U251; A172/TMZ; U251/TMZ

In vivo animal model:

-

circRNA-disease information
Expression pattern:
UP
Associated gene: KIF2A
Associated microRNA: miR-524-5p
Biological function: circHIPK3 knockdown facilitates TMZ sensitivity and apoptosis, and represses proliferation, migration, invasion, and metastasis in TMZ-resistant glioma cells.
Molecular mechanism: circHIPK3 acts as a sponge for miR-524-5p, thereby regulating KIF2A and the PI3K/AKT pathway to modulate TMZ resistance and cellular behaviors.
Biological pathway or process:

PI3K/AKT (promotes); apoptosis (inhibits); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); chemoresistance (promotes); ceRNA regulation (other)

Detected method:
Q
Validation methods:

RT-qPCR; Actinomycin D / DRB Stability Assay; Clinical Sample Validation; Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Luciferase Reporter Assay; Bioinformatics Analysis

Clinical significance:

CircHIPK3 may be a potential target for diagnosis and therapy of TMZ-resistant glioma and a favorable indicator to improve TMZ therapy.

Description:

circHIPK3 is up-regulated in TMZ-resistant glioma tissues and cells. Its knockdown increases TMZ sensitivity and apoptosis while inhibiting proliferation, migration, invasion, and metastasis. Mechanistically, circHIPK3 sponges miR-524-5p to regulate KIF2A and activate the PI3K/AKT pathway, supporting its potential therapeutic relevance in TMZ-resistant glioma.

Confidence score:

0.7164

Other information
Title:

Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: 2021
PubMed ID: 32833501
Study type:

combined biological and clinical study

Data availability: The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.
Code availability: -